Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10


Endophilin B2 facilitates endosome maturation in response to growth factor stimulation, autophagy induction, and influenza A virus infection.

Serfass JM, Takahashi Y, Zhou Z, Kawasawa YI, Liu Y, Tsotakos N, Young MM, Tang Z, Yang L, Atkinson JM, Chroneos ZC, Wang HG.

J Biol Chem. 2017 Jun 16;292(24):10097-10111. doi: 10.1074/jbc.M117.792747. Epub 2017 Apr 28.


Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.

Kanaoka R, Kushiyama A, Seno Y, Nakatsu Y, Matsunaga Y, Fukushima T, Tsuchiya Y, Sakoda H, Fujishiro M, Yamamotoya T, Kamata H, Matsubara A, Asano T.

PLoS One. 2015 Jun 3;10(6):e0127467. doi: 10.1371/journal.pone.0127467. eCollection 2015.


Ras and autophagy in cancer development and therapy.

Schmukler E, Kloog Y, Pinkas-Kramarski R.

Oncotarget. 2014 Feb 15;5(3):577-86. Review.


Stage-stratified analysis of prognostic significance of Bax-interacting factor-1 expression in resected colorectal cancer.

Ko YH, Cho YS, Won HS, An HJ, Sun DS, Hong SU, Park JH, Lee MA.

Biomed Res Int. 2013;2013:329839. doi: 10.1155/2013/329839. Epub 2013 Sep 23.


Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy.

Takahashi Y, Hori T, Cooper TK, Liao J, Desai N, Serfass JM, Young MM, Park S, Izu Y, Wang HG.

Blood. 2013 Feb 28;121(9):1622-32. doi: 10.1182/blood-2012-10-459826. Epub 2013 Jan 3.


Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation.

Runkle KB, Meyerkord CL, Desai NV, Takahashi Y, Wang HG.

Cancer Biol Ther. 2012 Aug;13(10):956-66. doi: 10.4161/cbt.20951. Epub 2012 Aug 1.


Bif-1 is overexpressed in hepatocellular carcinoma and correlates with shortened patient survival.

Fan R, Miao Y, Shan X, Qian H, Song C, Wu G, Chen Y, Zha W.

Oncol Lett. 2012 Apr 1;3(4):851-854. Epub 2012 Jan 12.


Autophagy in tumor suppression and cancer therapy.

Kung CP, Budina A, Balaburski G, Bergenstock MK, Murphy M.

Crit Rev Eukaryot Gene Expr. 2011;21(1):71-100. Review.


Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma.

Coppola D, Helm J, Ghayouri M, Malafa MP, Wang HG.

Pancreas. 2011 Apr;40(3):433-7. doi: 10.1097/MPA.0b013e318205eb03.


Autophagic pathways as new targets for cancer drug development.

Liu B, Cheng Y, Liu Q, Bao JK, Yang JM.

Acta Pharmacol Sin. 2010 Sep;31(9):1154-64. doi: 10.1038/aps.2010.118. Epub 2010 Aug 9. Review.

Supplemental Content

Support Center